DHA Oral Supplementation Modulates Serum Epoxydocosapentaenoic Acid (EDP) Levels in Breast Cancer Patients.

Alessio MolfinoMaria Ida AmabileLuana LionettoAlessandra SpagnoliCesarina RamacciniAlessandro De LucaMaurizio SimmacoMassimo MontiMaurizio Muscaritoli

Published in: Oxidative medicine and cellular longevity (2019)

DHA oral supplementation was associated with increased 19,20-EDP serum levels in BC patients, independent of the type of BC presentation, and in controls. Patients carrier of BRCA1/2 mutation seem to possess lower ability of DHA epoxidation, whereas luminal A-like BC patients showed higher EDP conversion. This behavior should be tested in a larger population.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors